In a global first, the United Kingdom has approved a gene-editing treatment for some rare blood diseases that may receive U.S. approval next month. Host Katherine Ellen Foley talks with POLITICO Europe health care reporter Carlo Martuscelli about the U.K. decision.
Learn more about your ad choices. Visit megaphone.fm/adchoices
